Review takes fizz out of Coca-Cola

Amelia Bott

StocksInValue

Review takes fizz out of Coca-Cola. Companies undergoing strategic reviews usually underperform for some time, reflecting entrenched legacy problems and the breadth and difficulty of corporate overhauls. Coca-Cola Amatil's (CCL) review was triggered by increasing competition, loss of pricing power, cost problems and a lack of product innovation. Although we are confident in an eventual recovery in the Australian business, this is some time away with new management's review only in its early stages. It will be some months at least until CCL's full response to its problems is announced, implemented and can be evaluated. Our FY15 valuation is $9.35 and we recommend buying only at a 10% discount to this valuation, or below $8.42. Read the full article by Daviw Walker published in Eureka Report (VIEW LINK)


Amelia Bott
Equities Analyst
StocksInValue

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.